Skip to main content
MGRX
NASDAQ Industrial Applications And Services

Mangoceuticals Reports Severe Cash Drain, Reiterates Going Concern, Faces Nasdaq Delisting, and Discloses Controversial CEO Subsidiary Agreement

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$0.43
Mkt Cap
$7.008M
52W Low
$0.162
52W High
$2.75
52W Position info
165% above low
Off High info
84% below high
Rel. Volume
Market data snapshot near publication time

MGRX has more than doubled off its 52-week low of $0.162.

Summary

Mangoceuticals reported a sharp decline in cash, a growing accumulated deficit, and reiterated its going concern warning, while also facing Nasdaq delisting and disclosing a controversial related-party agreement that shields its CEO from subsidiary losses.


Key Events · Legal and Risk Events · MGRX

  • Critical Liquidity Crisis

    Cash and cash equivalents dropped by 88% to $174,562 in Q1 2026, resulting in a $0.5 million working capital deficit. The company raised no new capital during the quarter.

  • Going Concern Warning Reiterated

    Management explicitly states current capital is insufficient to fund operations for the next 12 months, raising substantial doubt about the company's ability to continue as a going concern.

  • Nasdaq Delisting Risk

    The company received a non-compliance notice for its stock price and faces potential delisting, with limited options for another reverse stock split due to a prior 1-for-15 reverse split in October 2024.

  • Controversial CEO Subsidiary Agreement

    A 'Clarification Agreement' for subsidiary Mango & Peaches Corp. shields CEO Jacob Cohen from any losses or liabilities of his 49% common stock stake, while retaining rights to all positive economic value.


Analysis · MGRX · Industrial Applications And Services

Mangoceuticals' latest quarterly report reveals a critical financial situation, with cash reserves plummeting by 88% in three months and a working capital deficit of $0.5 million. The company explicitly states it lacks sufficient funding for the next 12 months, raising substantial doubt about its ability to continue as a going concern. Compounding these issues, the company is non-compliant with Nasdaq's minimum bid price rule and faces potential delisting, with limited options for a reverse stock split. A newly disclosed "Clarification Agreement" for its subsidiary, Mango & Peaches Corp., is particularly concerning, as it shields CEO Jacob Cohen from any losses or liabilities of the 49%-owned subsidiary while allowing him to benefit from its positive economic value. This arrangement, alongside a significant repricing of CEO stock options, raises serious corporate governance questions and indicates a misalignment of interests with common shareholders.

How filings like this one have moved

In the 30 days to Nov 6, 2026, 51.2% of the 201 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.73%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, MGRX was trading at $0.43 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $7M. The 52-week trading range was $0.16 to $2.75. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MGRX - Latest Insights

MGRX
Oct 09, 2026, 4:01 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.430
Real-time Price: $0.190 info
Change: -$0.240 (-56%) info
Market Cap: $4.263M info
MGRX
Oct 09, 2026, 4:00 PM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $0.4251
Real-time Price: $0.190 info
Change: -$0.2351 (-55%) info
Market Cap: $4.263M info
MGRX
Oct 06, 2026, 8:00 AM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $0.4107
Real-time Price: $0.190 info
Change: -$0.2207 (-54%) info
Market Cap: $4.263M info
MGRX
Oct 01, 2026, 3:50 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.4921
Real-time Price: $0.190 info
Change: -$0.3021 (-61%) info
Market Cap: $4.263M info
MGRX
Aug 21, 2026, 5:15 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.4021
Real-time Price: $0.190 info
Change: -$0.2121 (-53%) info
Market Cap: $4.263M info